Skip to main content

The first AHA Advice on sex and Countervailing Measures

January 19, 2012 (Houston, Texas) - A New advice suggests that sexual activity is safe for most patients with heart disease that doctors and patients and their partners should seek to debate the subject of sex [1]. The guidelines come from the first time, the American Heart Association (AHA) scientific statement on this issue, which is published online today in circulation.Lead author Dr Glenn N Levine (Baylor College of Medicine, Houston, TX) told heartwire that the guidelines are probably the most comprehensive on the subject to date and has been collected from various areas of expertise, including cardiology, exercise physiology, sexual counseling, and urology. Doctors, patients and partners do not want to talk about sexual activity, but it is something, which is an important quality of life for many people and we do not want to see patients to abstain from sex, from concern about the need to speed up the heart attack or sudden death, "- he notes.Only those patients who should abstain from sex with unstable heart disease or severe symptoms, they should be assessed and stabilized with appropriate treatment prior to sexual activity - Levine says. The drugs that can improve cardiovascular symptoms or survival should not be abandoned due to concerns that they may have an effect on sexual function - he notes.He also points out that while the use of phosphodiesterase-5 inhibitors (PDE-5), erectile dysfunction medications such as sildenafil (Viagra, Pfizer) is generally safe for men with stable cardiovascular disease, these drugs are absolutely contraindicated in patients taking nitrate therapy or long-acting preparations, or sublingual ones.Fear, anxiety and depression may lie to avoid GenderAHA recommendations are general guidelines of sexual activity and CVD, but also advice related to specific conditions: coronary artery disease, heart failure, valvular heart disease, those with heart rhythm and heart pacemakers or implantable cardioverter defibrillator ICDS) in patients with congenital heart disease and hypertrophic cardiomyopathy. And it includes the cardiovascular drugs and sexual function, as well as pharmacotherapy, sexual dysfunction.One of the main points of this statement, that doctors and health care providers know that this is a real problem that is not properly deal with the patient and partner and really should be, "- says Levine."At the same time, because we get a lot of unprofessional media attention to this problem - we hope that patients and their partners are aware that sexual activity is something they should feel free to visit the office to discuss with their health care providers, or until discharge from the hospital."It is important to emphasize is that the sexual intercourse the risk of heart attack is only a very slight increase in sexual activity and make only the minimum personal information overall level of risk.""Levine also want to emphasize the fact that anxiety and depression should be very important with regard to cardiovascular disease patients and may contribute to reduced or impaired sexual activity." Sexual counseling of compensating patients and their partners is an important component of recovery, unfortunately rarely, "- he and his co-authors to follow.Tips Help All doctors advise patients of compensation for sexThe scientific statement was published in the journal of cardiology, Levine noted cardiologist, because "going to be asked to comment on this, and often the GP will often refer to a cardiologist the patient deal with issues" related to sexual intercourse, he comments. For example, for one thing, it is often consulted by other physicians and patients can use in erectile dysfunction-drugs.However, Levine hopes that the new guidelines will encourage other professionals to ensure patient: "One of the goals is to allow general practitioners, family physicians, and others, at least for the majority of patients based guidelines."Another important aspect raised by the AHA statement, which was also confirmed by the American Urological Association, Society for Cardiovascular Angiography and interventions, Chest Surgery Society, the American heart and lung Rehabilitation Association, International Sexual Medicine Society, the American College of Cardiology Foundation, Heart Rate society, and heart failure Society of America - is that the heart of rehabilitation and regular physical activity can reduce cardiovascular complications in people with heart disease.Exercise testing can also provide additional information for an indefinite or uncertain-risk patients, the safety of sexual intercourse with the authors stress.They concluded that further research is needed on sexual activity in specific cardiovascular conditions, particularly in regard to women and older people.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volume delivered to

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n